Previous studies have reported that IL-15 can downregulate protein degradation in skeletal muscle from hepatitis-induced cachexia rats [81], regarded as an approach for the body to antagonize muscle atrophy during cachexia [82]. The gene discussed is IL15; the disease is Cachexia.